scholarly journals Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine

BMC Neurology ◽  
2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Andrew M. Blumenfeld ◽  
Sheena K. Aurora ◽  
Karen Laranjo ◽  
Spyros Papapetropoulos
Keyword(s):  
Chronic Migraine ◽  
Multicenter Study ◽  
Open Label ◽  
Term Efficacy

Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response

2008 ◽  
Vol 31 (7) ◽  
pp. 421-426 ◽  
Author(s):  
Yago González-Lama ◽  
Antonio López-San Román ◽  
Ignacio Marín-Jiménez ◽  
Begoña Casis ◽  
Isabel Vera ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Multicenter Study ◽  
Infliximab Therapy ◽  
Open Label ◽  
Predictors Of Response

scholarly journals Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

2022 ◽  
Vol 239 ◽  
pp. 83-91
Author(s):  
Yuriy Filts ◽  
Robert E. Litman ◽  
Javier Martínez ◽  
Lourdes Anta ◽  
Dieter Naber ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort

2018 ◽  
Vol 39 (S1) ◽  
pp. 159-160 ◽  
Author(s):  
Francesca Schiano di Cola ◽  
Elisa Pari ◽  
Salvatore Caratozzolo ◽  
Chiara Mancinelli ◽  
Paolo Liberini ◽  
...  
Keyword(s):  
Chronic Migraine ◽  
Term Efficacy

P150 LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

2020 ◽  
Vol 125 (5) ◽  
pp. S21
Author(s):  
A. Banerji ◽  
J. Hao ◽  
M. Yu ◽  
J. Bernstein ◽  
D. Johnston ◽  
...  
Keyword(s):  
Extension Study ◽  
Efficacy And Safety ◽  
Open Label ◽  
Term Efficacy ◽  
Open Label Extension

scholarly journals Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study

2016 ◽  
Vol 38 (9) ◽  
pp. 2058-2070.e1 ◽  
Author(s):  
Njira Lugogo ◽  
Christian Domingo ◽  
Pascal Chanez ◽  
Richard Leigh ◽  
Martyn J. Gilson ◽  
...  
Keyword(s):  
Efficacy And Safety ◽  
Open Label ◽  
Eosinophilic Asthma ◽  
Severe Eosinophilic Asthma ◽  
Term Efficacy ◽  
Phase Iiib ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document